You didn't decide to shorten the walk.

It happened over a couple of seasons. You took the flat way round because the hill seemed like a lot that day. Then you took it again. Now the flat way is just the way you go.

He still wants to go — that's what makes it confusing. He's at the door, lead in his mouth, the same dog. It's afterwards that changed. He used to come in, drink, and drop straight into his spot. Now there's a stretch on the kitchen floor where he's just recovering — standing, then lying, then finally settling — and it takes a while.

Here's the reframe: that gap isn't fitness. It's fuel.

One owner put it better than any of us do. “This looks like exercise intolerance to me, and this is shockingly unusual for this dog.” She didn't say he was sick. She said he was different.

The reason it shows up on the way home rather than the way out — there's one muscle in his body that has never had a night off.

• You take the flat route now, and you stopped calling it a detour
• You wait at the top of the hill instead of at the gate
• You cut the loop short and blamed the weather, twice, in the same week
• You started leaving a longer gap between the walk and dinner
• You quietly stopped bringing him on the big Sunday one
• You've caught yourself watching him settle instead of watching the road
• You've asked your vet about it, been told nothing is wrong, and still felt unsettled

If three or more landed, you're not imagining it — and you're not describing a disease. You're describing recovery.

Here's the piece nobody explains. Every muscle in your dog's body works in shifts. The legs push, then rest. The jaw chews, then stops. Sleep is when the system stands down and rebuilds.

One muscle never gets that. The diaphragm — the sheet of muscle under his ribs that drives every breath — has never had a night off since before he was born. It's striated muscle, the same family as the muscle in his legs: the same need for fuel, none of the downtime. So when fuel across the body runs thin, the always-on muscle has the least margin to absorb it.

And the fuel system does change with age. Cells run on a helper molecule called NAD+. In aging mice, NAD+ falls and an enzyme called CD38 climbs and drains it faster [1] — that part hasn't been studied in dogs yet, and we're not going to pretend otherwise. The mitochondria that spend NAD+ also get less efficient with age [2]. And one review across species notes the evidence for a universal decline is thinner than it's often made to sound [3] — which is why this page describes a mechanism, not a promise.

Worth saying plainly, and it matters more here than anywhere: talk to your vet about any change in your dog's breathing. Not next month — when you notice it. Changes in breathing can point to conditions that look similar and need a vet, not a supplement. If anything came on quickly, see your vet first.

Most owners reading this have already tried the obvious things, and tried them properly.

You gave him more rest days. You trimmed his weight, or you're working on it. Maybe you bought a senior supplement off the shelf, gave it a fair run, and quietly stopped when nothing changed. Somewhere in there you decided the slowdown was just the calendar and there was nothing to be done about it.

Rest was a reasonable idea. It just answers a different question.

Rest gives a muscle time. It doesn't give it fuel. If a muscle is short on what it needs to make energy, a day off doesn't restock it — and for the one muscle that can't take a day off in the first place, rest was never on the table.

Underneath it is something simpler than it sounds. Muscle cells are packed with mitochondria, and mitochondria are what turn food into usable energy. They run on NAD+. As that system gets less efficient with age [2], the cells that draw hardest on it are the ones that feel it first.

Biggest workload, no downtime, thinning supply. That's not a condition. That's an energy budget — and an energy budget is something you can actually do something about.

Pawprint Protocol was built with veterinary advisors around one job: give muscle cells the building block they use to make NAD+, in a form that absorbs.

The lead active is NMN — the direct building block for NAD+, and the only active here with published dog research behind it.

Here's what that research does and doesn't say, stated straight. In a study of dogs carrying a genetic muscle condition — category evidence for the pathway, not a study of this bottle — NAD+ was measurably low in their striated muscle, the same family the diaphragm belongs to, and an oral NAD+ precursor raised it and modestly moved some striated-muscle measures [4]. Most measures didn't move at all. Those dogs weren't healthy seniors. It's the direction that matters, not any number. Separately, oral NMN has been given to dogs and studied for safety — again, category evidence [5].

And in a randomised, placebo-controlled trial in senior dogs, an NAD+ precursor combination improved owner-assessed cognitive scores. That was a different product, not this one [6] — it proves nothing about Pawprint Protocol, and it measured cognition, not stamina. What it shows is that this pathway is worth taking seriously in dogs, not just in mice.

Use the dropper to add the recommended daily amount to your dog's food. Follow the directions on your bottle.

Owners tell us the first thing they notice isn't the walk. It's how quickly he's himself again afterwards.

The senior shelf at any pet store is a wall of the same promise: cushion the joint, ease the stiffness. Useful for some dogs. But none of it targets the muscle that never clocks off — and if it had been the answer for your dog you wouldn't have read this far.

Pawprint Protocol works one level down — at the muscle cell that powers the work, including the work that never stops. A few drops on his food, once a day.

Four actives, each with a job:

• NMN: The direct building block cells use to make NAD+, the fuel-helper molecule that declines with age. This is the hero, and the one with published dog research behind it.
• NAD+: Part of the same pathway, supporting the cellular energy system hardworking muscle runs on.
• Resveratrol: A plant compound studied alongside NAD+ for its role in the cell's energy and repair signalling.
• CoQ10: Sits inside the mitochondria — the tiny power plants in muscle cells — where energy actually gets made.

Pawprint Protocol combines NMN, NAD+, resveratrol, and CoQ10 in an easy-to-use liquid formula for dogs.

✔ Supports the cellular energy his respiratory muscles run on
✔ Supports the cellular energy that naturally declines with age
✔ Easy-to-use liquid drops
✔ Works alongside any food (kibble, raw, fresh, home-cooked)

Made for dogs 7 and up. 90-day money-back guarantee. Individual results may vary.

You don't have to wait three months to see anything. Most owners tell us the first changes show up in days to weeks — and on this angle they almost always show up after the walk rather than during it. Here's the pattern owners describe most often. Individual results may vary.

Small, and easy to miss if you're watching the walk itself. He comes in, drinks, and settles — without the long stretch of standing around in the kitchen first. One owner told us what she noticed first wasn't the walk at all: he'd stopped needing twenty minutes on the tile before lying down.

This is usually where the route quietly changes back. You take the way with the hill because it stopped feeling like a decision. He's at the top with you instead of behind you. The loop stretches out because he didn't turn for home — not because you pushed him further.

Owners often mention the second half of the day here. He's up for the evening one, not just the morning one. There's play in him after a walk instead of only before it. Good days stop being the exception and start being most days.

For most families this is the one they actually notice: you're back on the Sunday loop, and you can't say exactly when you started taking it again.

Three months in, the job changes from noticing to keeping. Age doesn't pause and NAD+ keeps declining, so the dogs who hold their ground are the ones who stay on it.

And it's worth saying plainly: the earlier a dog starts, the more there is to support. Individual results may vary.

The shortened walk wasn't the start of this. It was the part you could finally see.

Everything before it — the flat route, the longer settle, the Sunday loop you stopped suggesting — was the same thing showing up quietly. Nothing quit on him. The muscle that never gets a day off was working on a thinner supply.

That's supportable, and it starts with a few drops on dinner tonight. Any change in his breathing stays a conversation for your vet, not a label.

Reviews are unedited excerpts from verified Trustpilot reviews of Pawprint Lab. Individual results may vary.

[1] Camacho-Pereira, J. et al. CD38 Dictates Age-Related NAD Decline and Mitochondrial Dysfunction Through an SIRT3-Dependent Mechanism. Cell Metabolism, 2016;23:1127–1139. Mouse study. PMID 27304511.

[2] Chistiakov, D.A. et al. Mitochondrial Aging and Age-Related Dysfunction of Mitochondria. BioMed Research International, 2014. Review. PMID 24818134.

[3] Peluso, A. et al. Age-Dependent Decline of NAD+ — Universal Truth or Confounded Consensus? Nutrients, 2021;14. Review; it argues the evidence for a universal age-related decline is limited. PMID 35010977.

[4] Cardoso, D. et al. Replenishing NAD+ Content Reduces Aspects of Striated Muscle Disease in a Dog Model of Duchenne Muscular Dystrophy. Skeletal Muscle, 2023;13:16. Non-clinical dog disease model, not healthy aging dogs. Effect described as modest, most endpoints unchanged. PMID 38044436.

[5] You, J. et al. Subacute Toxicity Study of Nicotinamide Mononucleotide via Oral Administration. Frontiers in Pharmacology, 2020;11:604404. Safety study; the dog arm measured safety and serum nicotinamide. NAD+ was measured in mice, not dogs. PMID 33384603.

[6] Simon, K.E. et al. A Randomized, Controlled Clinical Trial Demonstrates Improved Owner-Assessed Cognitive Function in Senior Dogs Receiving a Senolytic and NAD+ Precursor Combination. Scientific Reports, 2024;14:12399. A different product, not Pawprint Protocol; the significant endpoint was an owner-reported cognition score, and measured activity did not differ. PMID 38811634.